Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.
作者信息
Van Eynde Aleyde, Litovkin Kirill, Bollen Mathieu
机构信息
Laboratory of Biosignaling and Therapeutics, Department of Molecular Cell Biology, Faculty of Medicine, KULeuven, Leuven B-3000, Belgium.
出版信息
Asian J Androl. 2011 Mar;13(2):205-6. doi: 10.1038/aja.2010.120. Epub 2010 Nov 22.
Abstract
摘要
相似文献
1
Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.假定的前列腺癌生物标志物PSP94和CRISP-3的生长抑制特性
Asian J Androl. 2011 Mar;13(2):205-6. doi: 10.1038/aja.2010.120. Epub 2010 Nov 22.
2
Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.PSP94 或 CRISP-3 介导的生长抑制具有前列腺癌细胞系特异性。
Asian J Androl. 2010 Sep;12(5):677-89. doi: 10.1038/aja.2010.56. Epub 2010 Aug 2.
3
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.富含半胱氨酸的分泌蛋白3和β-微精蛋白与根治性前列腺切除术后结局的关联
Clin Cancer Res. 2007 Jul 15;13(14):4130-8. doi: 10.1158/1078-0432.CCR-06-3031.
4
Purification and characterization of CRISP-3 from human seminal plasma and its real-time binding kinetics with PSP94.人精浆中CRISP-3的纯化、表征及其与PSP94的实时结合动力学
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Dec 15;1039:59-65. doi: 10.1016/j.jchromb.2016.10.032. Epub 2016 Oct 26.
5
Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.雄激素剥夺疗法对前列腺癌生物标志物 MSMB 和 MSMB 结合蛋白 CRISP3 表达的影响。
Prostate Cancer Prostatic Dis. 2010 Dec;13(4):369-75. doi: 10.1038/pcan.2010.25. Epub 2010 Aug 3.
6
Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.PSP94 的结构和分子生物学：在前列腺病理生理学中的意义。
Front Biosci (Landmark Ed). 2018 Jan 1;23(3):535-562. doi: 10.2741/4604.
7
beta-Microseminoprotein binds CRISP-3 in human seminal plasma.β-微精蛋白在人精液中与CRISP-3结合。
Biochem Biophys Res Commun. 2005 Jul 29;333(2):555-61. doi: 10.1016/j.bbrc.2005.05.139.
8
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.前列腺癌针吸活检中富含半胱氨酸的分泌蛋白 3 和β-微精囊蛋白对前列腺切除术的预后没有预测价值。
BJU Int. 2011 Oct;108(8):1356-62. doi: 10.1111/j.1464-410X.2010.10059.x. Epub 2011 Mar 16.
9
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.利用自动化图像分析评估 MSMB 和 CRISP3 在前列腺癌中的预后意义。
Mod Pathol. 2011 May;24(5):708-19. doi: 10.1038/modpathol.2010.238. Epub 2011 Jan 14.
10
Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells.雄激素受体介导的前列腺癌细胞中 CRISP3 启动子的表观遗传调控。
J Steroid Biochem Mol Biol. 2018 Jul;181:20-27. doi: 10.1016/j.jsbmb.2018.02.012. Epub 2018 Feb 22.
引用本文的文献
1
CAP superfamily proteins in human: a new target for cancer therapy.人类 CAP 超家族蛋白：癌症治疗的新靶点。
Med Oncol. 2024 Nov 5;41(12):306. doi: 10.1007/s12032-024-02548-6.
2
Is 37LRP cell surface receptor for PSP94?37LRP是PSP94的细胞表面受体吗？
Asian J Androl. 2011 Mar;13(2):347. doi: 10.1038/aja.2010.185. Epub 2011 Feb 7.
本文引用的文献
1
Novel approaches for the molecular classification of prostate cancer.前列腺癌分子分类的新方法。
Asian J Androl. 2010 Sep;12(5):620-2. doi: 10.1038/aja.2010.95. Epub 2010 Aug 16.
2
Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.PSP94 或 CRISP-3 介导的生长抑制具有前列腺癌细胞系特异性。
Asian J Androl. 2010 Sep;12(5):677-89. doi: 10.1038/aja.2010.56. Epub 2010 Aug 2.
3
Crystal structure of prostate secretory protein PSP94 shows an edge-to-edge association of two monomers to form a homodimer.前列腺分泌蛋白 PSP94 的晶体结构显示，两个单体以边缘到边缘的方式缔合形成同源二聚体。
J Mol Biol. 2010 Apr 9;397(4):947-56. doi: 10.1016/j.jmb.2010.02.035. Epub 2010 Feb 23.
4
The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.微精囊蛋白-β作为前列腺癌生物标志物和治疗靶点的潜在价值。
Prostate. 2010 Feb 15;70(3):333-40. doi: 10.1002/pros.21059.
5
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.对位于10q11.2染色体上与前列腺癌易感性相关的MSMB常见变异进行精细定位和功能分析。
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7933-8. doi: 10.1073/pnas.0902104106. Epub 2009 Apr 21.
6
The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins--roles in reproduction, cancer, and immune defense.CAP超家族：富含半胱氨酸的分泌蛋白、抗原5和病程相关蛋白1——在生殖、癌症和免疫防御中的作用
Endocr Rev. 2008 Dec;29(7):865-97. doi: 10.1210/er.2008-0032. Epub 2008 Sep 29.
7
Multiple newly identified loci associated with prostate cancer susceptibility.多个新发现的与前列腺癌易感性相关的基因座。
Nat Genet. 2008 Mar;40(3):316-21. doi: 10.1038/ng.90. Epub 2008 Feb 10.
8
Multiple loci identified in a genome-wide association study of prostate cancer.在一项前列腺癌全基因组关联研究中鉴定出多个基因座。
Nat Genet. 2008 Mar;40(3):310-5. doi: 10.1038/ng.91. Epub 2008 Feb 10.
9
Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males.血清中的β-微精蛋白与年轻健康男性精浆中的水平相关。
J Androl. 2008 May-Jun;29(3):330-7. doi: 10.2164/jandrol.107.003616. Epub 2008 Jan 24.
10
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.富含半胱氨酸的分泌蛋白3和β-微精蛋白与根治性前列腺切除术后结局的关联
Clin Cancer Res. 2007 Jul 15;13(14):4130-8. doi: 10.1158/1078-0432.CCR-06-3031.
Zotero 插件